LA
CRL icon

Lee Ainslie’s Charles River Laboratories CRL Stock Holding History

Lee Ainslie’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,178
Closed -$1.41M – 210
2026
Q1 		$1.41M Buy
+8,178
New +$1.52M 0.02% 107
2021
Q3 		– Sell
-1,536
Closed -$568K – 673
2021
Q2 		$568K Sell
1,536
-3,363
-69% -$1.12M 0.01% 370
2021
Q1 		$1.42M Buy
+4,899
New +$1.36M 0.01% 196
2020
Q4 		– Sell
-1,162
Closed -$263K – 694
2020
Q3 		$263K Buy
+1,162
New +$241K ﹤0.01% 468

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Lee Ainslie's CRL Position: Q2 2026 in Review

Lee Ainslie sold out of Charles River Laboratories (CRL) in Q2 2026, closing a stake of 8,178 shares — an estimated $1.41M sold.

Lee Ainslie first reported a position in CRL in Q3 2020 and held it in 4 quarters. The position peaked at $1.42M in Q1 2021. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Lee Ainslie reported no remaining Charles River Laboratories position as of Q2 2026 after selling out during the quarter.
  • Lee Ainslie sold 8,178 Charles River Laboratories shares in Q2 2026, an estimated $1.41M.
  • Lee Ainslie first reported a position in Charles River Laboratories in Q3 2020 and held it in 4 quarters.
  • Lee Ainslie's Charles River Laboratories position peaked at $1.42M in Q1 2021.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Maverick Capital's 13F filing for Q2 2026, filed 14 Aug 2026.